PHGDH: a metabolic switch in tumor drug resistance and a therapeutic target
{{output}}
Phosphoglycerate dehydrogenase (PHGDH) is the rate-limiting enzyme in the de novo serine biosynthesis pathway. Aberrant PHGDH overexpression has been observed in multiple malignancies and is closely associated with tumor progression, therapeutic resistance, an... ...
